Cargando…
Prevalence of Pretreatment HIV-1 Drug Resistance in Armenia in 2017–2018 and 2020–2021 following a WHO Survey
The increased antiretroviral therapy (ART) coverage of patients in the absence of routine genotyping tests and in the context of active labor migration highlight the importance of HIV-1 drug resistance (DR) surveillance in Armenia. We conducted a two-phase pretreatment DR (PDR) study in 2017–2018 (p...
Autores principales: | Kirichenko, Alina, Kireev, Dmitry, Lapovok, Ilya, Shlykova, Anastasia, Lopatukhin, Alexey, Pokrovskaya, Anastasia, Ladnaya, Natalya, Grigoryan, Trdat, Petrosyan, Arshak, Sarhatyan, Tatevik, Sargsyants, Narina, Hovsepyan, Tamara, Ghazaryan, Hovsep, Hovakimyan, Hermine, Martoyan, Siranush, Pokrovsky, Vadim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698750/ https://www.ncbi.nlm.nih.gov/pubmed/36366418 http://dx.doi.org/10.3390/v14112320 |
Ejemplares similares
-
Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries
por: Kirichenko, Alina, et al.
Publicado: (2022) -
HIV-1 Drug Resistance among Treatment-Naïve Patients in Russia: Analysis of the National Database, 2006–2022
por: Kirichenko, Alina, et al.
Publicado: (2023) -
Population Size Estimations Among Hidden Populations Using Respondent-Driven Sampling Surveys: Case Studies From Armenia
por: McLaughlin, Katherine R, et al.
Publicado: (2019) -
Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers
por: Kelly, Sherrie L, et al.
Publicado: (2016) -
Prevalence and risk factors of hepatitis C virus infection in Armenia, 2021
por: Demirchyan, A, et al.
Publicado: (2022)